semaglutide death Reduces MACE, in Impaired Kidney Function Obesity with established CVD: Semaglutide

However, the application is limited by the scarcity of donor tissue, additional trauma to the patient and surgical complications (Hao et al., 2022

Bioavailability of micronutrients from nutrient-dense whole foods: zooming in on dairy, vegetables, and fruits

Semaglutide-glycine blends and tirzepatide-glycine compounds are formulations that combine the GLP-1 medication with glycine, an amino acid that may enhance tolerability

Researchers at the University of British Columbia (UBC) found that patients taking GLP-1 drugs had a higher likelihood of developing stomach paralysis, pancreatitis, and bowel obstruction compared to individuals using bupropion-naltrexone, another weight loss medication

Early satiety and prolonged fullness result from the delayed gastric emptying caused by GLP-1 medications